本森飛曜 on TwitterRT
An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III
高端疫苗於友邦巴拉圭執行的免疫橋接「三期」臨床試驗報告,已正式發表在國際期刊上。
望周知🙏!An evaluation of the safety and immunogenicity of MV...
An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III
高端疫苗於友邦巴拉圭執行的免疫橋接「三期」臨床試驗報告,已正式發表在國際期刊上。
望周知🙏!An evaluation of the safety and immunogenicity of MV...